Research
Metabolic adaptation
Physical frailty and sarcopenia are associated with morbidity and 2-fold mortality in patients with advanced chronic liver disease awaiting liver transplantation.
Healthcare providers should assess frailty and sarcopenia in liver transplant candidates to improve outcomes.
StrongSupportsmedium confidence
Physical frailty and sarcopenia are increasingly associated with morbidity and 2-fold mortality in patients with advanced chronic liver disease awaiting liver transplantation (LT).
Why this rating
The claim is based on a synthesis of findings regarding frailty and sarcopenia in a specific patient population.
Source
Physical Frailty and Sarcopenia in Liver Transplantation: How Should They Be Assessed and Addressed?
Chiemelie Ngonadi et al. · Transplantation · 2025
reviewCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →